CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa)

Clinical trial NCT07153289 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07153289
Sponsor: University Hospital Tuebingen
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Carcinoma, Pancreatic Ductal Pancreatic Neoplasms

Start date: 2026-07-01
Primary completion: 2028-12-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.